Literature DB >> 12887400

Effects of local injection of prilocaine-felypressin on the myocardial oxygen balance in dogs.

Kenji Miyachi1, Tatsuya Ichinohe, Yuzuru Kaneko.   

Abstract

The authors investigated the effects of felypressin (Fely), a non-adrenergic vasoconstrictor, used together with prilocaine on myocardial oxygen balance. Six open-chest dogs were studied under urethane and alpha-chloralose anesthesia. Systolic arterial pressure, diastolic arterial pressure, mean pulmonary arterial pressure and pulmonary capillary wedge pressure, heart rate, coronary blood flow (CBF), internal and external myocardial oxygen tension (int- or ext-PmO2), and cardiac output were observed. Three doses of Citanest-Octapressin, which contains 3% prilocaine and 0.03 IU ml(-1) Fely (Pri-Fely) - 0.09, 0.18, and 0.3 ml kg(-1)- were injected into the tongue. Observations were performed up to 60 min after the injection. The CBF and int-PmO2 was reduced following the injection of each of the three doses of Pri-Fely. There were negative correlations between the Pri-Fely dose per body weight and the maximum reductions in CBF (r = -0.52, P < 0.05), in int-PmO2 (r = -0.78, P < 0.05), and in ext-PmO2 (r = -0.55, P < 0.05), respectively [corrected]. These results suggest that an administration of Fely at doses more than 2.7-5.4 mIU kg(-1) (3-6 cartridges of Pri-Fely) may induce an imbalance between the oxygen supply and demand in myocardial tissues of patients with cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887400     DOI: 10.1034/j.1600-0722.2003.00050.x

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  2 in total

1.  Cardiovascular effects of felypressin.

Authors:  Rodrigo Cecanho; Laurival Antonio De Luca; José Ranali
Journal:  Anesth Prog       Date:  2006

2.  Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia.

Authors:  Stig Müller; Ole-Jakob How; Stig Eggen Hermansen; Thor Allan Stenberg; Georg Sager; Truls Myrmel
Journal:  Crit Care       Date:  2008-02-21       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.